Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

NCT04877691 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

367

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Medi-546
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]